What Attys Need To Know As Landmark Opioid Trial Begins
Law360 (May 24, 2019, 4:13 PM EDT) -- Two decades into a coast-to-coast overdose epidemic, Big Pharma on Tuesday faces an opioid crisis reckoning, with Johnson & Johnson squaring off against Oklahoma's attorney general in a historic trial with multibillion-dollar implications for corporate coffers and addiction treatment.
Barring an eleventh-hour settlement, the showdown in state court in Norman, home of the University of Oklahoma, will be the first of roughly 2,000 opioid lawsuits filed by state and local governments to go to trial. It's a milestone for the nationwide litigation wave, which blames the pharmaceutical industry for pervasive drug abuse linked to 400,000 deaths involving prescription and illicit opioids...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!